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1. Introduction 
It has been previously reported that the tissue 
content of cyclic AMP in rat mammary gland 
rises continuously to the end of pregnancy and then 
falls progessively to its lowest value by the 16th day 
of lactation [ 11, suggesting that the growth and 
development of the gland are related to the issue content 
of cyclic AMP, while the initiation, and scale, of 
lactation may be related to the decreasing content 
of the nucleotide. In studies with rat mammary 
gland explants in culture [2] cyclic AMP inhibited 
the increase of enzyme activities normally associated 
with lactogenesis, in particular the activities of those 
enzymes involved in lipogenesis, and also markedly 
depressed the synthesis of DNA, RNA and fatty acids. 
This analogy with the pleiotypic response observed for 
other cells grown in culture [3], and the reversal by 
cyclic GMP of the pleiotypic inhibition of 3T3 cells 
treated with dibutyryl cyclic AMP [4] , led us to 
investigate the simultaneous fluctuations of both 
cyclic nucleotides throughout the lactation cycle. 
differentiation of the mammary gland during preg- 
nancy, its response to hormones and the promotion 
of specific cell programmes for the synthesis of the 
characteristic components of milk may all be 
mediated by modification of the ratio between the 
two nucleotides. 
2. Methods 
Mated female rats were taken either on the lOth, 
15th or 20th days of pregnancy or on the 1 st, 10th 
or 15th days of lactation and their abdominal 
mammary glands removed under nembutal anaesthesia 
preparatory to freezeclamping the tissue. The nucleo- 
tides were extracted as previously described [6] and 
then freeze-dried. They were dissolved, immediately 
before use, in 10 mM acetate buffer, pH 4.0, to give 
an extract equivalent to 1 g tissue/ml. 
2.1. Measurement of cyclic AMP and cyclic GMP 
Cyclic AMP was estimated by a radioisotope 
dilution method with cyclic AMP-binding protein 
[ 1,6] . Cyclic GMP was assayed by a modification 
of a described method [7] using 600 l.(g of a cyclic 
GMP-binding protein purified from lobster-tail muscle 
through the ammonium sulphate (55%) stage [8] . 
No further purification of the dialysed ammonium 
sulphate fraction was attempted as this results in 
severe losses of cyclic GMP-binding activity [9] . 
40 11 of tissue or milk extract were used in a final 
incubation volume of 100 ~1. The millipore filters 
with the protein-bound cyclic GMP were dried and 
placed in counting vials containing 15 ml of 
The results reported here show a coordinated 
change in the levels of cyclic AMP and cyclic GMP 
during the different stages of the cycle, with the 
cyclic AMP being high during pregnancy and low 
in lactation and cyclic GMP showing the reverse 
pattern, which supports the hypothesis [5] that 
cyclic GMP is involved im promoting cellular events 
that are antagonistic to those mediated by an eleva- 
tion of cellular cyclic AMP. The process of 
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scintillaut (4 g POP; 0.45 g dimethyl POPOP/litre 
toluene) and counted (40% efficiency). 
For each tissue sample, the milk content was 
determined and a correction applied for the cyclic 
AMP and cyclic GMP contents of the milk in the 
extract. 
3. Results and discussion 
The content of cyclic AMP and cyclic GMP in the 
rat mammary gland at different stages of the lactation 
cycle are shown in Fig. 1, where the results are given 
as pmoles X g-r. (although it may be noted that a 
very similar pattern is obtained when the results are 
expressed on the total tissue basis). 
The results show an opposite, and coordinated, 
change in the levels of the two nucleotides throughout 
the lactation cycle with the cyclic AMP being high 
during pregnancy and low in lactation while cyclic 
GMP shows the reverse pattern. The values for 
Pregnancy Lactation 
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Fig. 1. ‘Iissue contents of cyclic AMP 2nd cyclic GMP in the 
rat mammary gland at different stages of the lactation cycle. 
Results are given as the mean values f SEM and are expressed 
as pmoles X g-r milk-free tissue. (Rat milk contained 25000 
* 140 pmoles of cyclic AMP and 264 f 27 pmoles cyclic 
GMP per ml). Each value represents the mean of not less than 
5 animals. (0) cyclic AMP (o) Cyclic GMP. * 
cyclic AMP shown here conform closely to those 
previously reported [l] . The ratio cyclic AMP/cyclic 
GMP shows a diphasic pattern, with a rapid, and 
continuous rise throughout pregnancy and a profound 
decline during lactation. The transition, at parturition, 
coincides in time with the considerable increase in the 
metabolic activity of the gland consequent on the 
initiation of lactation. The inverse relationship between 
the tissue cyclic AMP content and a number of 
metabolic parameters, suggesting that the develop- 
ment of the gland is related to its content of cyclic 
Ah4P and the initiation and scale of lactation to the 
removal of the nucleotide, has been discussed 
elsewhere [ 1,2,6] . 
The tissue content of cyclic GMP, which is about 
2 X 10e7M at the middle of pregnancy, declines 
slowly, but continuously, during this stage to reach 
only about 50% of this value near parturition, and 
then starts increasing again in lactation finally to 
reach its peak on the 15th day of lactation (3.5 X 
10m7M). The minimum value of 10e7M at the end 
of pregnancy and the maximum of 3.5 X 10e7 M at 
the peak of lactation are both within the range of 
concentrations found in many other tissues [S] and 
comparable, for example, to the changes reported for 
rat heart after perfusion with acelycholine (l-3 X 
10e7M) [lo]. At the middle of pregnancy, the concen- 
trations of both cyclic nucleotides are very similar 
(cyclic AMP/cyclic GMP = 0.81) but, near parturition 
the level of cyclic AMP is about seven times that of 
cyclic GMP and at the end of lactation the cyclic 
GMP content has risen to nearly twice that of the 
cyclic AMP (ratio = OSS), clearly showing that each 
nucleotide preponderates in one of the two main stages 
of the lactation cycle. Although it is generally consid- 
ered that the cyclic GMP concentration in a given 
tissue is usually l/lOth to l/lOOth of the level of 
cyclic AMP in the same tissue, there are many condi- 
tions in which they are more comparable, e.g. cere- 
bellum, rat thymus gland and lung, sperm, guinea 
pig macrophages etc. [5,1 I] . The fact that the cyclic 
AMP content in milk (2.5 X 10m6M) is lo-times 
that of cyclic GMP (2.6 X 10m7M) at a stage at which 
the difference in the intracellular concentrations of 
the nucleotides is less manifest, suggests that the 
rate of extrusion of the cellular cyclic GMP from 
mammary tissue is lower than that for cyclic AMP 
and that this may serve to maintain a high level of 
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cyclic GMP in the tissue during lactation. The high 
extrusion rate of cyclic AMP into the milk may re- 
present a mechanism for ensuring the maintenance of 
low levels of the nucleotide during lactation. 
Further support for the reciprocal control of tissue 
concentrations of the two nucleotides may be adduced 
from regulatory influences acting at the level of their 
enzymatic hydrolysis by phosphodiesterase. Beavo 
et al. [ 121 reported that concentrations of cyclic GMP 
in the range 8 X 1 Oe8 -2 X 10m6 M can stimulate 
(2-3 fold) the rate of the phosphodiesterasecatalyzed 
hydrolysis of cyclic AMP in a number of mammalian 
tissues. It has also been observed that a regulatory 
mechanism by which the cyclic AMP levels are 
modulated by increasing cyclic GMP exists in 
thymocytes and fibroblasts [13,14]. 
Although cyclic GMP may exert an independent, 
or mono-directional, role of considerable importance 
during lactogenesis by its known stimulatory effect 
on protein synthesis [ 15,161, the coordinated and op- 
posite changes of the two cyclic nucleotides through- 
out the lactation cycle is suggestive and may indicate 
that the antagonism between cyclic AMP and cyclic 
GMP could be the main modulatory mechanism for 
the adaptation of the gland and for its responsiveness 
to hormonal stimulation. The present results support 
the hypothesis of Goldberg et al. [S] that there are 
bidirectional systems in which stimulation or inhibi- 
tion of a process is achieved by a simultaneous drop 
in concentration of cyclic AMP as that of cyclic 
Ghap is increased. 
This ‘dualistic’ hypothesis is supported by many 
observations that cyclic GMP promotes events in 
the cell that are antagonistic to those mediated by 
cyclic AMP, e.g. the promotion of differentiation 
by high intracellular concentrations of cyclic AMP 
and of mitogenesis by high levels of cyclic GMP 
[17-191 ; the effect of cyclic AMP to decrease the 
responsiveness of postganglionic neurones to impulses 
and of cyclic GMP to increase it [20] ; the require- 
ment of a certain ratio of the two nucleotides to 
mediate the induction of the immune response [Zl] ; 
some hormone action, like that of insulin; which 
acts to lower the intracellular level of cyclic AMP, 
may also cause a marked increase of cyclic GMP [7] 
and the fact that cyciic GMP maybe related to the 
F-prostaglandins, much as cyclic AMP relates to the 
E-prostaglandins, these being the two types of 
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prostaglandins of opposite action [22] . 
Some of these activities may be highly relevant 
to the mammary gland a) the role of cyclic AMP as 
promoter of differentiation could be of special 
significance to the development of the gland during 
pregnancy, a stage at which the level of this nucleo- 
tide is high; b) the rise of cyclic GMP after the onset 
of lactation may explain the wave of mitosis which 
follows shortly after parturition in the rat [23], a 
process which is also significant (in addition to 
increasing the number of secretory cells present) in 
that it may, as suggested by Stockdale and Topper 
[24] , make these cells specially susceptible to 
environmental factors capable of modifying the 
metabolic pattern; c) the complex endocrine control 
of the mammary gland and the tissue response to 
hormones may be expressed through the dualistic 
system of opposing cyclic AMP and cyclic GMP 
levels which could, as has already been shown for 
other cells grown in culture [3,4] , also modulate the 
pleiotypic control of mammary cells [2] . 
It is possible that, at the time of parturition, 
changes of the various factors which oppose the 
production, or action, of cyclic AMP would be 
initiated by the generation of one, or more, ‘active 
signals’, as has been proposed by Goldberg et al. for 
other tissues [ 51, represented by an elevation of the 
cyclic GMP concentration and that the signals lowering 
the cyclic AMP level are complementary events 
permitting a greater response linked to cyclic GMP. 
The fact that cyclic GMP promotes the hydrolysis 
of cyclic AMP by the phosphodiesterase [ 121, an enzyme 
the activity of which is increased in the mammary 
gland with the onset of lactation [ 1,6] , lends support 
to the idea that cyclic GMP contributes actively to the 
depletion of cyclic AMP which follows parturition. 
In addition to this dualistic system of control, 
performed by the opposing action of cyclic AMP 
and cyclic GMP, it seems probable that each cyclic 
nucleotide may exert its own monodirectional modula- 
tory control at different levels in the metabolic 
machinery of the cell although it may be that the effect 
of cyclic AMP in the mammary gland is different from 
the pattern obtaining in general in other tissues where 
the presence of cyclic AMP is primarily linked to the 
mobilization of energy reserves and the production of 
energy. 
. 
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